Singapore Institute of Advance Medicine (SGX:9G2) was granted a two-month extension of time from the Singapore Exchange Regulation to release its fiscal 2024 results and to convene its annual general meeting.
The company was previously supposed to release financial results for fiscal 2024 by Aug. 29, and to hold its AGM by Oct. 31, according to a filing with the Singapore Exchange on Wednesday.
The healthcare company also secured a two-month extension from its current deadline of Oct. 16 to issue its annual return for fiscal 2024.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。